Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 970	$ 859
Receivables, net	216	253
Inventories, net	135	144
Related party receivables	6	11
Prepaid expenses and other contract assets	36	47
Other current assets	18	18
Assets held for sale	26	317
Total current assets	1,407	1,649
Property, plant and equipment, net	395	473
Operating lease right-of-use assets	96	100
Equity method investment	79	87
Goodwill	289	290
Intangible assets, net	12	17
Deferred tax assets	7	7
Other Long-term Investments	10	9
Other non-current assets	26	111
Total assets	2,321	2,743
Liabilities and equity
Accounts payable	233	233
Related party payables	2	3
Accrued expenses	198	192
Income tax payable	26	7
Other current liabilities	41	38
Liabilities held for sale	7	118
Total current liabilities	507	591
4% Convertible Senior Notes due 2024 (Carrying value)	163	160
Pension liability	17	17
Deferred tax liabilities	13	13
Operating lease non-current liabilities	78	82
Finance lease non-current liabilities	34	33
Other non-current liabilities	27	29
Total non-current liabilities	332	334
Equity
Common stock  (par value $1.00, $325 million shares authorized, 111 million shares issued and outstanding as of March 31, 2020 and December 31, 2019)	111	111
Additional paid-in capital	2,345	2,343
Accumulated deficit	(914)	(681)
Accumulated other comprehensive loss	(60)	(44)
Total equity	1,482	1,729
Non-controlling interest	0	89
Total equity and non-controlling interest	1,482	1,818
Total liabilities, equity and non-controlling interest	$ 2,321	$ 2,743
Shares Issued (in shares)	111,000,000	111,000,000
Shares Outstanding (in shares)	111,000,000	111,000,000
Shares Authorized (in shares)	325,000,000	325,000,000
Par Value (in dollars per share)	$ 1.00	$ 1.00